800.692.4380
Used for 20 minutes, once or twice a day, the Fisher Wallace Stimulator® is cleared by the FDA for the treatment of depression, anxiety and insomnia. In clinical trials, the majority of patients experienced durable reduction or remission of symptoms within the first two weeks of daily use. Patients may return their device for a refund if it does not reduce their symptoms. The device is comfortable and easy to use, and works by stimulating the brain to produce serotonin and lower cortisol, without the side effects of medication. The device is safe to use in conjunction with antidepressant and anxiety medication, or may be used as a standalone therapy. No negative effects resulting from long term use of the device have been reported since the device first came to market in 1990.
Invented by electrical engineers in partnership with physicians and research scientists, the Fisher Wallace Stimulator® received FDA-Clearance for the treatment of depression, anxiety, insomnia in 1990 under the original brand name Liss Cranial Stimulator®. In 2006, entrepreneur Charles Fisher and addiction researcher Martin Wallace, PhD, purchased the patents to the device and Kelly Roman later joined as co-founder. By 2010, several hundred psychiatrists were prescribing the device and finding it to be effective with thousands of treatment-resistant patients. Additional clinical research was launched at Mount Sinai Beth Israel Hospital and Phoenix House, and a landmark bipolar depression study was published in 2015. In 2017, Medicaid in Maine (MaineCare) approved the Fisher Wallace Stimulator® for full coverage. Today, more than 9000 providers - including psychiatrists, primary care providers, and telemedicine providers - recommend the Fisher Wallace Stimulator® to their patients.
Device Specific Research
Device Class Research
The Fisher Wallace Stimulator® often works for patients who have found previous forms of therapy to have lost effectiveness over time, such as drug therapy, psychotherapy, and rTMS.
38% of patients experience side effects from using antidepressant medication - including very serious side effects.1 By comparison, less than 1% of patients experience side effects - all minor - from using the Fisher Wallace Stimulator®.
1. Real-World Data on SSRI Antidepressant Side Effects. Psychiatry (Edgmont). 2009 Feb; 6(2): 16–18.
38% of patients experience side effects from using antidepressant medication - including very serious side effects.1 By comparison, less than 1% of patients experience side effects - all minor - from using the Fisher Wallace Stimulator®.
1. Real-World Data on SSRI Antidepressant Side Effects. Psychiatry (Edgmont). 2009 Feb; 6(2): 16–18.
No medication, device or other form of therapy is effective for 100% of patients. That's why we offer a 30-day refund period. And if you need to extend your trial period, simply let us know and we will accommodate you.
Designed collaboratively by world-class engineers and doctors, the Fisher Wallace Stimulator® uses proprietary waveforms to gently stimulate the brain to produce serotonin and other neurochemicals responsible for healthy mood and sleep. Proven safe and effective in multiple published studies, the device is cleared by the FDA to treat depression, anxiety and insomnia. Watch the video to learn how easy it is to use.
Our industry-leading refund policy allows patients to return their Fisher Wallace Stimulator® for a refund within 30 days of receipt, or request an extension to their trial period for up to an additional 30 days (60 days total). Fisher Wallace applies a 15% return fee to cover the cost of medical device processing and does not refund the cost of shipping. Refund checks are mailed within five weeks following receipt of an undamaged device.
